Plain-English translation of NCT07110454 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Epilepsy research guide โThis is a follow-up study for people who already received the Minder System, an FDA-approved implanted device that helps detect seizures that standard tests might miss. Researchers want to understand how this device helps doctors make better treatment decisions for epilepsy over the long term. You'll continue your regular care with your doctor while the study tracks how the device is working for you.
Many people with epilepsy have seizures that don't show up on standard brain monitoring tests, making it hard for doctors to diagnose and treat them properly. This study exists to learn whether this new device helps doctors better understand and manage epilepsy over time in patients who haven't responded well to other treatments.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You'll visit your epilepsy doctor every six months for two years while keeping your Minder device. At each visit, doctors will check how you're doing, review data from your device, and ask about your overall health and any seizures you've experienced. The study mainly involves continuing your normal epilepsy care while researchers collect information about how the device is helping guide your treatment decisions.
AI-generated summary from trial data ยท Jul 18, 2026 ยท Not medical advice
United States